Esperion Therapeutics' aggressive commercialization efforts have significantly boosted retail prescriptions and broadened ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Thank you for standing by and welcome to Heron Therapeutics ...

Axsome Therapeutics surpassed revenue expectations in Q3, driven by strong sales from its key products.

It has been years since I have considered restarting a position in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) after having ...

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

We intend to achieve our goals with a high-performing team committed to execute, focus and innovate to drive our continued growth and long-term transformation ... To report SUSPECTED ADVERSE REACTIONS ...

These three emerging technology leaders are pioneering quantum computing, gene editing, and electric aviation.

Nov. 12, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq ... Voyager is committed to maintaining a strong balance ...

This was partly offset by a 1% rise in the company’s revenue from $46 billion to $47 billion over the same period; and a 4.1% ...

The job cuts are part of a business restructuring to reduce costs, 23andMe says. Along with layoffs, the company is ...

The Clark County Council is revisiting a request from ZP#5 LLC, a company controlled by Washougal Pit mine owner Judith ...